|
gptkb:TSC1
|
genetic testing for TSC1 mutations
|
|
gptkb:NTLA-6001
|
gptkb:United_Kingdom
|
|
gptkb:PCV24
|
ongoing as of 2024
|
|
gptkb:GORE_CARDIOFORM_Septal_Occluder
|
REDUCE trial
|
|
gptkb:KoviVac_COVID-19_vaccine
|
Phase III (as of 2021)
|
|
gptkb:ABG20
|
Phase 2
|
|
gptkb:VAL208
|
preclinical
|
|
gptkb:COL4A5_gene
|
genetic testing for Alport syndrome
|
|
gptkb:COVID-19_mRNA_vaccines
|
Phase 3 completed
|
|
gptkb:QazCovid-in
|
Phase III
|
|
gptkb:DSG2
|
yes
|
|
gptkb:NCT03830207
|
Phase 3
|
|
gptkb:Iveric_Bio
|
gptkb:GATHER2
|
|
gptkb:DENVax
|
Phase 3
|
|
gptkb:PRF1_gene
|
genetic testing for HLH
|
|
gptkb:PRKAR1A
|
available
|
|
gptkb:DB15054
|
Phase 3
|
|
gptkb:STX-478
|
Phase 1/2
|
|
gptkb:GBP510_COVID-19_vaccine
|
Phase 3
|
|
gptkb:Vir_Biotechnology,_Inc.
|
COMET-ICE
|